17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
5
(5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomalß-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.
Orleans University
5
Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerfulß-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomalß-galactosidase.
Graz University of Technology
3
Pharmacological chaperones as therapeutics for lysosomal storage diseases.
Amicus Therapeutics
14
Biological properties of D- and L-1-deoxyazasugars.
Toyama Medical and Pharmaceutical University
37
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
Northwestern University
16
Derivatives of (2R,3R,4S)-2-aminomethylpyrrolidine-3,4-diol are selective alpha-mannosidase inhibitors.
Section De Chimie De L'Universit£
2
Concise synthesis of (+)-conduritol F and inositol analogues from naturally available (+)-proto-quercitol and their glucosidase inhibitory activity.
Chulalongkorn University
4
A fluorescent probe for GM1 gangliosidosis relatedß-galactosidase: N-(dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol.
Industrial Research
1
Synthesis and biological evaluation of (11)C-labeled beta-galactosyl triazoles as potential PET tracers for in vivo LacZ reporter gene imaging.
Katholieke Universiteit Leuven
1
1-Deoxygalactonojirimycin-lysine hybrids as potent D-galactosidase inhibitors.
Technische UniversitäT Graz
6
Synthesis of [(2S,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-5-methylfuran-4-carboxylic acid derivatives: new leads as selective beta-galactosidase inhibitors.
Universidad De Sevilla
1
Synthesis of alpha-C(1-->3)-mannopyranoside of N-acetylgalactosamine, a new beta-galactosidase inhibitor.
Institut De Chimie Organique De L'Université
9
Pharmaceutical significance of azepane based motifs for drug discovery: A critical review.
Wuhan Institute of Technology
2
Specific, uncompetitive inhibition of beta-galactosidases by a 5,6-isopropylidenedioxyfuro[2,3-d]isoxazole-3-methanol derivative.
Institut De Chimie Organique De L'Université
5
4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to β-galactosidase mutations: Improved synthesis and biological investigations.
Orleans University